[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![yorvel5 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1069757293.png) yorvel5 [@yorvel5](/creator/twitter/yorvel5) on x X followers
Created: 2025-07-27 16:31:55 UTC

Citizens reiterated $MDGL Mkt OP/$470 after its 2Q25 survey showed a XX% prescription rate for Rezdiffra (up from XX% in its 1Q survey)" $IVA $AKRO $ALGS $VKTX ETNB SGMT LLY #MASH Citizens in its note to investors said, "Our 2Q25 survey shows a XX% prescription rate for Rezdiffra (up from XX% in our 1Q survey), with ~60% of patients on paid drug and consistent high persistence; we reiterate our Market Outperform rating and $XXX risk-adjusted, DCF-derived price target on Madrigal Pharmaceuticals. Most metrics in our 2Q25 physician survey improved from 1Q, which is a good sign coming out of the typical 1Q reimbursement dynamics. Citizens additionally said:

![](https://pbs.twimg.com/media/Gw4KrzvWkAAgeJa.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1949508058675093999/c:line.svg)

**Related Topics**
[algs](/topic/algs)
[$algs](/topic/$algs)
[$akro](/topic/$akro)
[$iva](/topic/$iva)
[op](/topic/op)
[$mdgl](/topic/$mdgl)
[$vktx](/topic/$vktx)

[Post Link](https://x.com/yorvel5/status/1949508058675093999)